TrialAnnals of the rheumatic diseases2008

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

C Miceli-Richard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.